BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38116190)

  • 1. Cytotoxic T-lymphocyte-associated antigen 4
    Mirsharif ES; Rostamian A; Salehi M; Askari N; Ghazanfari T
    Heliyon; 2024 Jan; 10(1):e23308. PubMed ID: 38116190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of Association between CTLA-4 Gene Polymorphisms and Colorectal Cancers in Saudi Patients.
    Al-Harbi N; Abdulla MH; Vaali-Mohammed MA; Bin Traiki T; Alswayyed M; Al-Obeed O; Abid I; Al-Omar S; Mansour L
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between CTLA-4 + 49A > G and - 318C > T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm.
    Abtahi S; Izadi Jahromi F; Dabbaghmanesh MH; Malekzadeh M; Ghaderi A
    Endocrine; 2018 Oct; 62(1):159-165. PubMed ID: 30078171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of CTLA-4 gene polymorphisms -318C/T and +49A/G and Hashimoto's thyroidits in Zahedan, Iran.
    Narooie-Nejad M; Taji O; Kordi Tamandani DM; Kaykhaei MA
    Biomed Rep; 2017 Jan; 6(1):108-112. PubMed ID: 28123718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T lymphocyte-associated antigen 4 rs231775 polymorphism and osteosarcoma.
    Bilbao-Aldaiturriaga N; Patino-Garcia A; Martin-Guerrero I; Garcia-Orad A
    Neoplasma; 2017; 64(2):299-304. PubMed ID: 28052683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of cytotoxic T-lymphocyte-associated protein 4 codon 17 variant and expression on vitiligo risk.
    Gouda NS; Fawzy MS; Toraih EA
    J Clin Lab Anal; 2021 Jun; 35(6):e23777. PubMed ID: 33932254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of CTLA-4 and CD86 gene polymorphisms in Iranian patients with brucellosis infection.
    Eskandari-Nasab E; Moghadampour M; Najibi H; Hadadi-Fishani M
    Microbiol Immunol; 2014 Feb; 58(2):135-41. PubMed ID: 24298899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTLA-4 (+49A/G) Polymorphism in Type 1 Diabetes Children of Sudanese Population.
    Khalid Kheiralla KE
    Glob Med Genet; 2021 Mar; 8(1):11-18. PubMed ID: 33748819
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of cytotoxic T lymphocyte antigen-4 (CTLA-4) promoter -318C/T and +49A/G gene polymorphisms in Turkish patients with familial Mediterranean fever.
    Gunesacar R; Erken E; Dinkci S
    Cell Biochem Biophys; 2013 Mar; 65(2):181-6. PubMed ID: 22923220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between CTLA-4 rs231775 polymorphism and hepatocellular carcinoma susceptibility.
    Liu Z; Song Z; Sun J; Sun F; Li C; Sun J; Xu L
    Int J Clin Exp Pathol; 2015; 8(11):15118-22. PubMed ID: 26823853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTLA-4 (+49A/G) and NOD2/CARD15 (N852S) polymorphisms with inflammatory bowel disease in Turkish patients.
    Budak Diler S; Yaraş S
    Cell Mol Biol (Noisy-le-grand); 2018 Aug; 64(11):97-101. PubMed ID: 30213296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the CTLA4 +49A/G (rs231775) and CT60 (rs3087243) gene variants with vitiligo: study on a Mexican population.
    Salinas-Santander MA; Suárez-Valencia VJ; Ángel-Martínez MD; Kubelis-Lopez DE; Zapata-Salazar NA; Ocampo-Garza JA; Ocampo-Candiani J
    An Bras Dermatol; 2022; 97(6):710-715. PubMed ID: 36163113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of CTLA-4 gene polymorphism with end-stage renal disease and renal allograft outcome.
    Misra MK; Kapoor R; Pandey SK; Sharma RK; Agrawal S
    J Interferon Cytokine Res; 2014 Mar; 34(3):148-61. PubMed ID: 24313821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic T lymphocyte antigen 4 (CTLA4) gene polymorphism with bladder cancer risk in North Indian population.
    Jaiswal PK; Singh V; Mittal RD
    Mol Biol Rep; 2014 Feb; 41(2):799-807. PubMed ID: 24390231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between CTLA-4 gene polymorphism and myasthenia gravis in a Chinese cohort.
    Cai GM; Gao Z; Yue YX; Xie YC; Gao X; Hao HJ; Zhang XJ; Wang Q; Liang B; Li HF
    J Clin Neurosci; 2019 Nov; 69():31-37. PubMed ID: 31473094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTLA-4 gene 49A/G polymorphism in Turkish patients with Behçet's disease.
    Sallakci N; Bacanli A; Coskun M; Yavuzer U; Alpsoy E; Yegin O
    Clin Exp Dermatol; 2005 Sep; 30(5):546-50. PubMed ID: 16045690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of CTLA-4 (+ 49A/G) polymorphism association with rheumatoid arthritis in Egyptian patients.
    Ragab D; Hammoda RM; El-Gharbawy NH; Salem R
    Egypt J Immunol; 2023 Jul; 30(3):180-189. PubMed ID: 37440667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms at +49A/G and CT60 sites in the 3' UTR of the CTLA-4 gene and APECED-related AIRE gene mutations analysis in sporadic idiopathic hypoparathyroidism.
    Goswami R; Gupta N; Ray D; Rani R; Tomar N; Sarin R; Vupputuri MR
    Int J Immunogenet; 2005 Dec; 32(6):393-400. PubMed ID: 16313305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of CTLA-4 (+49 A/G) polymorphism with susceptibility to autoimmune diseases: A meta-analysis with trial sequential analysis.
    Yu L; Shao M; Zhou T; Xie H; Wang F; Kong J; Xu S; Shuai Z; Pan F
    Int Immunopharmacol; 2021 Jul; 96():107617. PubMed ID: 33866246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTLA-4 +49A>G polymorphism is associated with the risk but not with the progression of colorectal cancer in Chinese.
    Qi P; Ruan CP; Wang H; Zhou FG; Xu XY; Gu X; Zhao YP; Dou TH; Gao CF
    Int J Colorectal Dis; 2010 Jan; 25(1):39-45. PubMed ID: 19787358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.